Shares in London-listed drugmakers GSK and Astrazeneca tumbled on Monday morning after President Donald Trump said the US’ ...

AstraZeneca opens a $300 million cell therapy manufacturing facility in Rockville, boosting the local biotech industry.

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

Drugmakers said it could cost them $1 trillion over the next decade. A U.S. appeals court shut down AstraZeneca’s challenge to the U.S. government program that gives Medicare the power to ...

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...

AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...